Effects of the Covid-19 Pandemic on Gestational Diabetes in Castilla La Mancha (Spain)

Le résumé fourni par la source

Abstract Aim: To assess the effect of the coronavirus disease 2019 (COVID-19) pandemic on gestational diabetes mellitus (GDM). Methods: In this observational, multicentre, retrospective study conducted in Castilla La Mancha, Spain, we compared 663 women with GDM exposed to pandemic (pandemic group) with 622 women with GDM who were attended 1 year before (prepandemic group). The primary outcome was large for gestational age (LGA) newborns as an indicator of GDM poor control. Secondary outcomes included maternal and neonatal morbidity. Results: During the pandemic the gestational week at diagnosis (24.2 ± 7.4 vs 22.9 ± 7.7, p = 0.0016) and at the first visit to Endocrinology (26.6 ± 7.2 vs 25.3 ± 7.6, p = 0.0014) were earlier. Face-to-face visits were maintained to a large extent (80.3%). The new diagnostic criteria of GDM was only used in the 3% of cases. However, in the pandemic group the final HbA1c was higher (+ 0.09%, p = 0.047) and there were more LGA newborns (8.5% vs 12.8%, p = 0.015). There were no differences in perinatal complications. Conclusion: Medical care for GDM in our Public Health System did not suffer a significant deterioration during the pandemic. However, this did not prevent a greater number of LGA newborns. The use of temporary alternatives for the diagnosis of GDM during the Covid-19 pandemic was associated with having a LGA newborn. These diagnostic criteria should be reconsidered or maybe in future pandemics we should maintain the usual diagnostic protocol.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.